P38 map kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/12 (2006.01) A61K 31/415 (2006.01) A61P 11/00 (2006.01) A61P 29/00 (2006.01) C07D 401/14 (2006.01) C07D 403/12 (2006.01)

Patent

CA 2746354

The present disclosure relates to compounds of formula (I): which are inhibitors of p38 mitogen-activated protein kinase enzymes,particularly the alpha and gamma kinase sub-types thereof, and their use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as COPD

Cette invention concerne des composés de formule (I) : qui sont des inhibiteurs de protéine kinase activée par le mitogène p38, en particulier de sous-types alpha et gamma kinase, et leurs utilisations thérapeutiques ainsi que des de compositions pharmaceutiques utilisées, en particulier pour le traitement de maladies inflammatoires, notamment du poumon tels que les broncho-pneumopathies chroniques obstructives du poumon (BPCO).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

P38 map kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with P38 map kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P38 map kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1919712

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.